Physician profile
Majed Mouded
NPI 1346248531
$2,598.55
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,093 · 2020: $491 · 2021: $14.76.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $445.60 | 2019-2021 | |
| Pfizer INC. | $306.65 | 2019-2020 | |
| Amgen INC. | $267.64 | 2019 | |
| Sanofi-Aventis U.S. LLC | $198.49 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $173.27 | 2019-2020 | |
| Glaxosmithkline, LLC. | $166.32 | 2019-2020 | |
| Amarin Pharma, INC. | $163.89 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $94.62 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $77.30 | 2019-2020 | |
| Shire North American Group INC | $76.89 | 2019 | |
| Novo Nordisk INC | $74.10 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $63.40 | 2019-2020 | |
| Mylan Specialty L.P. | $58.05 | 2019-2020 | |
| Abbott Laboratories | $53.31 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $49.11 | 2019 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $42.01 | 2019 | |
| Lifescan, INC. | $39.89 | 2019 | |
| Arbor Pharmaceuticals, INC. | $32.06 | 2019 | |
| Novartis Pharmaceuticals Corporation | $29.65 | 2019 | |
| Valeritas, INC. | $23.55 | 2019 | |
| Abbvie INC. | $20.33 | 2019 | |
| Ironwood Pharmaceuticals, INC | $19.37 | 2019 | |
| Companion Medical, INC. | $19.13 | 2019 | |
| Melinta Therapeutics, LLC | $16.77 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.94 | 2020 | |
| Ultragenyx Pharmaceutical INC. | $15.86 | 2020 | |
| Medtronic Minimed, INC. | $15.78 | 2019 | |
| Sunovion Pharmaceuticals INC. | $15.46 | 2019 | |
| Allergan, INC. | $13.21 | 2019 | |
| Biodelivery Sciences International, INC. | $10.90 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Majed Mouded listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.